Revive Therapeutics's total assets for Q1 2024 were C$10.05M, a decrease of -5.52% from the previous quarter. TSE:RVV total liabilities were C$3.29M for the fiscal quarter, a -3.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.